Dupilumab in persistent asthma with elevated eosinophil levels.

Volume: 368, Issue: 26, Pages: 2455 - 2466
Published: Jun 26, 2013
Abstract
Background Moderate-to-severe asthma remains poorly treated. We evaluated the efficacy and safety of dupilumab (SAR231893/REGN668), a fully human monoclonal antibody to the alpha subunit of the interleukin-4 receptor, in patients with persistent, moderate-to-severe asthma and elevated eosinophil levels. Methods We enrolled patients with persistent, moderate-to-severe asthma and a blood eosinophil count of at least 300 cells per microliter or a...
Paper Details
Title
Dupilumab in persistent asthma with elevated eosinophil levels.
Published Date
Jun 26, 2013
Volume
368
Issue
26
Pages
2455 - 2466
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.